Riskpilot← Back to searchSign inGet full accessØJESTEN, BRILLER OG KONTAKTLINSER ApS
APSActiveCVR 32649270Blæsbjerggade 2BRetail sale of medical and orthopaedic goods · NACE 4774Est. 20094 employeeswww.ojesten.com
Revenue 2025
DKK 5,7M
+18% vs 2024
EBITDA margin
29.8%
+18% vs 2024
Equity ratio
40.7%
Financial strength
Net profit 2025
DKK 1,1M
+27% vs 2024
| Revenue | DKK 5,7M | +18% |
| EBITDA | DKK 1,7M | +18% |
| Net profit | DKK 1,1M | +27% |
| Total assets | DKK 7M | +6% |
| Equity | DKK 2,8M | +43% |
| Employees | 4 | — |
Legal name
ØJESTEN, BRILLER OG KONTAKTLINSER ApS
CVR number
32649270
Legal form
Anpartsselskab
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
7. december 2009
Share capital
DKK 125.000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion.
Company purpose
Selskabets formål er at drive brillevirksomhed og virksomhed med salg af livsstilsprodukter samt virksomhed og investeringer i relation hertil.
Address
Blæsbjerggade 2B
Phone
+4575508887
Email
info@ojesten.com
Website
www.ojesten.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4.278 | 4.847 | 4.787 | 4.841 | 5.689 |
| Staff expenses | -3.025 | -3.480 | -3.532 | -3.347 | -3.926 |
| EBITDA | 1.170 | 1.239 | 1.200 | 1.439 | 1.693 |
| Depreciation & amort. | -265 | -309 | -286 | -226 | -223 |
| EBIT | 905 | 930 | 914 | 1.213 | 1.469 |
| Net financials | -187 | -230 | -86 | -142 | -120 |
| Profit before tax | 718 | 700 | 829 | 1.071 | 1.350 |
| Tax | 159 | 156 | 184 | 242 | 297 |
| Net profit | 559 | 545 | 645 | 829 | 1.053 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 8.431 | 7.464 | 6.647 | 6.595 | 6.986 |
| Equity | 3.368 | 2.913 | 3.158 | 1.987 | 2.840 |
| Long-term debt | 2.310 | 1.665 | 1.573 | 1.547 | 1.519 |
| Short-term debt | 2.740 | 2.865 | 1.889 | 3.046 | 2.627 |
| Total debt | 5.050 | 4.530 | 3.463 | 4.593 | 4.146 |
EBITDA margin
29.8%
This company
15.8%
Market median
+89% vs market
20212025
Equity ratio
40.7%
This company
38.2%
Market median
+7% vs market
20212025
Return on equity
37.1%
This company
18.4%
Market median
+102% vs market
20212025
Net profit margin
18.5%
This company
8.1%
Market median
+128% vs market
20212025
Asset turnover
0.81×
This company
1.12×
Market median
+28% vs market
20212025
Debt / equity
1.46×
This company
0.62×
Market median
-135% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TK Management | Management | 2009 |
LV Management | Management | 2010 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2010 | |
| Company | 50–66.65% | 50–66.65% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
LVN INVEST ApS
ØJESTEN, BRILLER OG KONTAKTLINSER ApS Board members of ØJESTEN, BRILLER OG KONTAKTLINSER ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Troels Kjærholm | Management | 0 companies |
| Lone Vivian Bang Nielsen | Management | 0 companies |